510(k) K253044

RXiBreeze PAP System (RXiBreeze 20C) by Resvent Medical Technology Co., Ltd. — Product Code BZD

K253044 is an FDA 510(k) premarket notification submitted by Resvent Medical Technology Co., Ltd. for the device "RXiBreeze PAP System (RXiBreeze 20C)". The FDA issued a decision of Substantially Equivalent on Jul 23, 2026. The device falls under product code BZD (Ventilator, Non-Continuous (Respirator)), a Class II device regulated under 21 CFR 868.5905.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jul 23, 2026
Date Received
Sep 22, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Ventilator, Non-Continuous (Respirator)
Device Class
Class II
Regulation Number
868.5905
Review Panel
AN
Submission Type
510(k)

Source: FDA 510(k) database entry for K253044. Report a data issue: hello@regdatalab.com.